Fang, Yujing
Skog, Sven
Ou, Qingjian
Chen, Zhiheng
Liu, Senbo
Hei, Ailian
Li, Jin
Zhou, Ji
He, Ellen
Wan, Desen
Article History
Received: 1 December 2022
Accepted: 11 January 2023
First Online: 17 February 2023
Declarations
:
: All patients gave informed consent to participate in this study, which was conducted in accordance with the 1964 <i>Helsinki Declaration and the Harmonized Tripartite Guideline for Good Clinical Practice from the International Conference on Harmonization</i>. This clinical study was approved by the ethics committee of Sun Yat-sen University Cancer Centre (No. GZR2011-10).
: No conflict of interest was reported except for Ji Zhou, who is the president of Sino-Swed Tongkang Bio-Tech, Inc., which produced the STK1p kit.